Welcome to our dedicated page for Datametrex AI news (Ticker: DTMXF), a resource for investors and traders seeking the latest updates and insights on Datametrex AI stock.
Datametrex AI Limited reports developments across technology solutions, artificial intelligence and healthcare, with recurring updates tied to data centre operations, private cloud infrastructure and managed services for enterprise customers. Company announcements describe purchase orders for hyperconverged infrastructure software, technical support and AI-enabled resource optimization, including work delivered through Datametrex Korea.
News also covers the company's use of AI-assisted functionality in electronic medical records and the intellectual property activities of wholly owned subsidiary Paymetrex Payment Solutions Inc. Paymetrex updates include patent licensing and monetization initiatives involving secure transaction processing, payment authorization workflows, mobile-based acceptance architectures and potential relevance to SoftPOS and next-generation secure payment environments.
Datametrex (OTC:DTMXF) subsidiary Paymetrex launched a patent licensing program to monetize its mobile payments IP portfolio, which includes nine issued U.S. and Canadian patents filed as early as 2011.
Paymetrex says portions of the portfolio are already licensed; the program targets payment processors, fintechs, merchants and infrastructure providers operating in large, fast-growing mobile wallet markets.
Datametrex AI (OTC:DTMXF) will participate in the AlphaNorth Capital Event hosted by CEM from January 16–18, 2026. The event schedules one-on-one meetings for growth-stage companies in Resource, Technology, Biotech, and Special Situations sectors to meet capital markets participants and professional investors. Datametrex said it will discuss its progress, strategy, and growth initiatives with existing and prospective investors. Event details are available on the conference website and participation runs across the full day of scheduled meetings.
Datametrex (OTC:DTMXF) announced that its Korea subsidiary secured new purchase orders with a combined value of approximately CAD $400,000 on January 8, 2026. The orders are expected to generate about CAD $400,000 in revenue with an estimated profit margin of 17.5%. The company said the contracts support its global growth strategy and "land and expand" approach, reinforcing Datametrex's role as a provider of IT infrastructure and technology solutions to large global enterprises.
Management highlighted continued demand from enterprise partners and noted the Korean subsidiary as a key contributor to revenue growth.
Datametrex (OTC:DTMXF) subsidiary Paymetrex entered a Technology Licensing Agreement dated December 17, 2025 with AnywhereCommerce to access its payment products and services.
Paymetrex will combine AnywhereCommerce technology with its proprietary IP, market payment solutions under the YuzuPay brand via direct sales, ISVs and ISOs, and appoint resellers across luxury merchant categories. Paymetrex holds a 10‑patent granted portfolio and plans to file at least one provisional patent for quantum‑enhanced payment security.
The release cites AnywhereCommerce's deployment of 20 million devices across 15 countries and a Grand View Research crypto payments market projection from USD 556.9M (2024) to USD 2.4B (2033) at a 17.8% CAGR.
Datametrex (OTC:DTMXF) completed the acquisition of the Yuzu payment processing solution from Firstpayment via subsidiary Paymetrex on December 19, 2025. The purchase price was $5.5 million, satisfied by issuance of 55,000,000 common shares at a deemed price of $0.10 per share, subject to a four-month-and-one-day hold period.
The company did not assume Firstpayment debt. Proceeds from a prior private placement were released from escrow to fund integration of Yuzu and merchant commercialization efforts. Michael Kron was appointed to the board and now holds approximately 12.15% of outstanding common shares.
Datametrex (OTC:DTMXF) signed a definitive asset purchase agreement dated December 9, 2025 to acquire the Yuzu payment processing solution, including related patents and intellectual property, from Firstpayment for a purchase price of $5.5 million.
The purchase price will be satisfied by issuing 55,000,000 common shares at a deemed price of $0.10 per share to Firstpayment. Completion is expected on or about December 17, 2025, subject to customary closing conditions and TSXV approval.
Upon closing, proceeds from a previously announced private placement will be released from escrow to integrate Yuzu into Datametrex's technology division and pursue merchant revenue opportunities; Michael Kron is expected to join the board and serve as COO of Paymetrex.
Datametrex (OTC:DTMXF) announced on December 1, 2025 that its wholly owned subsidiary Imagine Health has launched walk-in services at Calgary and Edmonton clinics, and is accepting new family patients.
Both clinics operate Monday to Friday, 8:30 AM–4:30 PM, and will treat same-day, non-emergency needs including respiratory infections, minor injuries, urgent prescriptions, and chronic condition flare-ups. Locations, phone numbers, and clinic hours are provided for patient access.
The company said the expansion advances its goal of improving timely, patient-focused care across Western Canada and signals continued exploration of broader clinic network growth.
Datametrex (OTC:DTMXF) announced on November 27, 2025 that its subsidiary Datametrex Korea secured purchase orders totaling approximately CAD $650,000. The P.O.s represent roughly CAD $650,000 in new revenue with an approximate 20% gross profit margin. The company described the orders as part of its land and expand strategy and said they reinforce its role as an IT infrastructure solutions provider to major global partners.
The announcement highlights contribution from Korean operations and management commentary emphasizing continued partnership-driven growth and operational execution.
Datametrex AI (OTC:DTMXF) announced that its wholly owned subsidiary Imagine Health added four new physicians and is accepting new patients in Calgary and Edmonton as of November 24, 2025.
Calgary clinics added Dr. Younis, Dr. Rezaeisarlak, and Dr. Fiselier to expand insured primary-care services under Alberta's provincial system. Edmonton clinic added Dr. Abdulkadir to increase capacity and access. The release lists clinic addresses, phone numbers, fax numbers, and Monday–Friday hours for booking appointments.
DataMetrex (OTC:DTMXF) announced that subsidiary Imagine Health Medical Clinics has reopened its Edmonton South clinic at 2551 Hewes Way NW, Suite 104, Edmonton, AB T6L 6W6. The new facility is open and accepting new patients seeking a family physician.
Clinic contact: (780) 468-5999, fax 1 (855) 751-0323. Hours: Monday–Friday, 8:30 AM–4:30 PM. Management said the relocation provides a modern, accessible space intended to support patient-focused care across Alberta.